Analyzing Akoya Biosciences (NASDAQ:AKYA) and Singular Genomics Systems (NASDAQ:OMIC)
Analyzing Akoya Biosciences (NASDAQ:AKYA) and Singular Genomics Systems (NASDAQ:OMIC)
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) and Akoya Biosciences (NASDAQ:AKYA – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.
納斯達克：OMIC-GET評級公司和赤谷生物科學公司(納斯達克：AKYA-GET評級)都是小盤醫療公司，但哪隻股票更好？我們將根據這兩家公司的收益、股息、盈利能力、分析師建議、機構所有權、風險和估值等方面的實力進行對比。
Profitability
盈利能力
This table compares Singular Genomics Systems and Akoya Biosciences' net margins, return on equity and return on assets.
此表比較了Single Genonomy Systems和Akoya Biosciences的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Singular Genomics Systems | N/A | -29.16% | -25.41% |
| Akoya Biosciences | -99.49% | -70.53% | -37.60% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 奇異基因組學系統 | 不適用 | -29.16% | -25.41% |
| Akoya生物科學 | -99.49% | -70.53% | -37.60% |
Earnings and Valuation
收益和估值
This table compares Singular Genomics Systems and Akoya Biosciences' revenue, earnings per share and valuation.
這張表格比較了單基因組系統公司和Akoya生物科學公司的收入、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Singular Genomics Systems | N/A | N/A | -$98.77 million | ($1.25) | -1.69 |
| Akoya Biosciences | $54.92 million | 7.45 | -$42.94 million | ($1.85) | -5.83 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 奇異基因組學系統 | 不適用 | 不適用 | -9,877萬元 | ($1.25) | -1.69 |
| Akoya生物科學 | 5492萬美元 | 7.45 | -4,294萬元 | ($1.85) | -5.83 |
Analyst Recommendations
分析師建議
This is a summary of recent ratings and target prices for Singular Genomics Systems and Akoya Biosciences, as reported by MarketBeat.com.
據MarketBeat.com報道，這是Single Genome Systems和Akoya Biosciences最近的評級和目標價格摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Singular Genomics Systems | 1 | 2 | 0 | 0 | 1.67 |
| Akoya Biosciences | 0 | 0 | 5 | 0 | 3.00 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 奇異基因組學系統 | 1 | 2 | 0 | 0 | 1.67 |
| Akoya生物科學 | 0 | 0 | 5 | 0 | 3.00 |
Singular Genomics Systems currently has a consensus target price of $3.50, suggesting a potential upside of 65.88%. Akoya Biosciences has a consensus target price of $17.80, suggesting a potential upside of 65.12%. Given Singular Genomics Systems' higher possible upside, analysts plainly believe Singular Genomics Systems is more favorable than Akoya Biosciences.
奇異基因組公司目前的共識目標價為3.50美元，這意味着潛在的上行空間為65.88%。Akoya Biosciences的共識目標價為17.80美元，暗示潛在上漲65.12%。考慮到單一基因組系統公司更有可能的上行空間，分析師們顯然認為，單一基因組系統公司比Akoya Biosciences更有利。
Insider & Institutional Ownership
內部人與機構所有權
56.3% of Singular Genomics Systems shares are owned by institutional investors. Comparatively, 34.6% of Akoya Biosciences shares are owned by institutional investors. 22.6% of Singular Genomics Systems shares are owned by company insiders. Comparatively, 9.2% of Akoya Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
奇異基因系統公司56.3%的股份由機構投資者持有。相比之下，Akoya Biosciences 34.6%的股份由機構投資者持有。奇異基因系統公司22.6%的股份由公司內部人士持有。相比之下，Akoya Biosciences 9.2%的股份由公司內部人士持有。強大的機構持股表明，大型基金管理公司、捐贈基金和對衝基金相信，一家公司有望實現長期增長。
Volatility and Risk
波動性和風險
Singular Genomics Systems has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Akoya Biosciences has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
奇異基因系統公司的貝塔係數為0.84，這表明其股價的波動性比標準普爾500指數低16%。相比之下，Akoya Biosciences的貝塔係數為0.97，這表明其股價的波動性比標準普爾500指數低3%。
Summary
摘要
Singular Genomics Systems beats Akoya Biosciences on 8 of the 13 factors compared between the two stocks.
奇異基因組學系統公司在兩隻股票之間的13個因素中有8個超過了Akoya Biosciences。
About Singular Genomics Systems
關於奇異基因組學系統
(Get Rating)
(獲取評級)
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
單一基因組系統公司是一家生命科學技術公司，開發下一代測序和多組學技術，為研究人員和臨牀醫生製造產品，促進科學和醫學的發展。該公司製造G4儀器，一種臺式下一代測序儀，用於產生基因測序結果，以及相關的消耗品套裝菜單。它還提供PX集成解決方案，將單細胞分析、空間分析、基因組學和蛋白質組學結合到一個集成儀器中，提供多功能的多組學解決方案。該公司與安捷倫技術公司、Dovetail基因組公司、利克森公司、New England Biolab公司、QIAGEN公司、羅氏公司、Twist Bioscience公司和鐘錶製造商基因組公司建立了合作伙伴關係，以在G4上驗證他們的圖書館準備試劑盒，並與麻省理工學院和哈佛大學的博德研究所和哈佛大學合作，將G4連接到Terra平臺，這是一個數據平臺。Single Genome Systems，Inc.成立於2016年，總部位於加利福尼亞州拉荷亞。
About Akoya Biosciences
關於Akoya Bioscions
(Get Rating)
(獲取評級)
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Akoya Biosciences，Inc.是一家生命科學技術公司，提供空間生物學解決方案，專注於改變北美、亞太地區、歐洲、中東和非洲的發現和臨牀研究。該公司提供PhenoCycler儀器和PhenoImager平臺，PhenoCycler儀器是一個緊湊的臺式流體系統，與配套顯微鏡集成以實現圖像採集自動化；PhenoImager平臺使研究人員能夠利用自動化和高通量的工作流程可視化、分析、量化新鮮冰凍或FFPE組織切片中的原位細胞和組織微陣列。它還提供PhenoCycler和PhenoImager試劑；以及生物製藥服務。此外，該公司還提供基於雲的平臺Proxima，用於存儲、分析和共享空間數據；INFORM組織，用於準確可視化和量化組織切片中的生物標記物的自動化圖像分析軟件包；Phenoptr，提供合併和分析INFO軟件創建的輸出表的功能；以及PhenoptrReports，一種在直觀的前端圖形用户界面中基於Phenoptr輸出生成可共享報告和可視化的軟件。該公司成立於2015年，總部位於馬薩諸塞州馬爾伯勒。
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.
《奇異基因組學系統日報》獲得新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊，接收最新新聞的每日簡明摘要和分析師對Single Genome Systems及相關公司的評級。